BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

519 related articles for article (PubMed ID: 16098294)

  • 1. Treatment of non-Hodgkin's lymphoma (NHL) with radiolabeled antibodies (mAbs).
    DeNardo GL
    Semin Nucl Med; 2005 Jul; 35(3):202-11. PubMed ID: 16098294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose intensified molecular targeted radiotherapy for cancer-lymphoma as a paradigm.
    DeNardo G; DeNardo S
    Semin Nucl Med; 2010 Mar; 40(2):136-44. PubMed ID: 20113681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perspectives on cancer therapy with radiolabeled monoclonal antibodies.
    Sharkey RM; Goldenberg DM
    J Nucl Med; 2005 Jan; 46 Suppl 1():115S-27S. PubMed ID: 15653660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioimmunotherapy of relapsed non-Hodgkin's lymphoma with zevalin, a 90Y-labeled anti-CD20 monoclonal antibody.
    Wiseman GA; White CA; Witzig TE; Gordon LI; Emmanouilides C; Raubitschek A; Janakiraman N; Gutheil J; Schilder RJ; Spies S; Silverman DH; Grillo-López AJ
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3281s-3286s. PubMed ID: 10541376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Harnessing the energy: development of radioimmunotherapy for patients with non-Hodgkin's lymphoma.
    Gregory SA; Hohloch K; Gisselbrecht C; Tobinai K; Dreyling M
    Oncologist; 2009; 14 Suppl 2():4-16. PubMed ID: 19819920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiolabeled immunotherapy in non-Hodgkin's lymphoma treatment: the next step.
    Otte A; van de Wiele C; Dierckx RA
    Nucl Med Commun; 2009 Jan; 30(1):5-15. PubMed ID: 19020470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of 131I-tositumomab.
    Lewington V
    Semin Oncol; 2005 Feb; 32(1 Suppl 1):S50-6. PubMed ID: 15786026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors affecting 131I-Lym-1 pharmacokinetics and radiation dosimetry in patients with non-Hodgkin's lymphoma and chronic lymphocytic leukemia.
    DeNardo GL; DeNardo SJ; Shen S; DeNardo DA; Mirick GR; Macey DJ; Lamborn KR
    J Nucl Med; 1999 Aug; 40(8):1317-26. PubMed ID: 10450684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Final results of a phase I radioimmunotherapy trial using (186)Re-epratuzumab for the treatment of patients with non-Hodgkin's lymphoma.
    Postema EJ; Raemaekers JM; Oyen WJ; Boerman OC; Mandigers CM; Goldenberg DM; van Dongen GA; Corstens FH
    Clin Cancer Res; 2003 Sep; 9(10 Pt 2):3995S-4002S. PubMed ID: 14506199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of radioimmunotherapy for the treatment of non-Hodgkin's lymphoma.
    Multani P
    Int J Hematol; 2002 Dec; 76(5):401-10. PubMed ID: 12512834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioimmunotherapy for non-Hodgkin's lymphoma: a review for radiation oncologists.
    Macklis RM; Pohlman B
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):833-41. PubMed ID: 16965871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody-guided radiation therapy of cancer.
    Koppe MJ; Postema EJ; Aarts F; Oyen WJ; Bleichrodt RP; Boerman OC
    Cancer Metastasis Rev; 2005 Dec; 24(4):539-67. PubMed ID: 16408161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cure of incurable lymphoma.
    DeNardo GL; Sysko VV; DeNardo SJ
    Int J Radiat Oncol Biol Phys; 2006; 66(2 Suppl):S46-56. PubMed ID: 16979440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioimmunotherapy of B-cell non-Hodgkin's lymphoma: from clinical trials to clinical practice.
    Juweid ME
    J Nucl Med; 2002 Nov; 43(11):1507-29. PubMed ID: 12411555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioimmunotherapy of B-cell non-Hodgkin's lymphoma.
    Postema EJ; Boerman OC; Oyen WJ; Raemaekers JM; Corstens FH
    Eur J Nucl Med; 2001 Nov; 28(11):1725-35. PubMed ID: 11702116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current status of cancer therapy with radiolabeled monoclonal antibody.
    Oriuchi N; Higuchi T; Hanaoka H; Iida Y; Endo K
    Ann Nucl Med; 2005 Jul; 19(5):355-65. PubMed ID: 16164191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab and other emerging monoclonal antibody therapies for lymphoma.
    Tobinai K
    Expert Opin Emerg Drugs; 2002 Oct; 7(2):289-302. PubMed ID: 15989552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conventional treatments for non-Hodgkin's lymphoma: the need for new therapies.
    Moskowitz CH
    J Nucl Med; 1998 Aug; 39(8 Suppl):2S-10S. PubMed ID: 9708564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Radioimmunotherapy of follicular lymphoma: a step towards cure?].
    Ketterer N; Bischof Delaloye A; Helg C; Luthi F; Buchegger F
    Bull Cancer; 2007 Sep; 94(9):799-806. PubMed ID: 17878100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioimmunotherapy of the Non-Hodgkin's Lymphomas.
    Knox SJ
    Semin Radiat Oncol; 1995 Oct; 5(4):331-341. PubMed ID: 10717155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.